Matrine suppresses hepatocellular carcinoma tumorigenesis by modulating circ_0055976/miR‐1179/lactate dehydrogenase A axis

Abstract

AbstractBackgroundMatrine has been identified to have anticancer activity in hepatocellular carcinoma (HCC). Circ_0055976 was highly expressed in HCC. Here, we investigated the function and relationship of Matrine and circ_0055976 in HCC tumorigenesis.MethodsCell proliferation and invasion were detected using Cell Counting Kit‐8, 5‐Ethynyl‐2′‐deoxyuridine (EdU), colony formation and transwell assays, respectively. Cell aerobic glycolysis was evaluated by detecting glucose consumption, lactate production, and the ratios of ATP/ADP. Levels of genes and proteins were detected by quantitative real‐time polymerase chain reaction and Western blotting. The target relationship between miR‐1179 and circ_0055976 or lactate dehydrogenase A (LDHA) was analyzed by dual‐luciferase reporter assay. The mouse xenograft model was established to conduct the in vivo assay.ResultsMatrine suppressed HCC cell proliferation, invasion and anaerobic glycolysis in vitro. Circ_0055976 was highly expressed in HCC tissues and cells, and was reduced by Matrine treatment. Moreover, overexpression of circ_0055976 reversed the anticancer effects of Matrine in HCC cells. Mechanistically, circ_0055976/miR‐1179/LDHA formed an axis. Circ_0055976 knockdown or miR‐1179 overexpression impaired HCC cell proliferation, invasion, and anaerobic glycolysis, which were reversed by miR‐1179 inhibition or LDHA overexpression. Meanwhile, forced expression of LDHA abolished the regulatory effects of Matrine on HCC cells. In the clinic, Matrine impeded HCC tumor growth in vivo, and this effect was boosted after circ_0055976 silencing.ConclusionMatrine suppressed HCC cell proliferation, invasion, and anaerobic glycolysis via circ_0055976/miR‐1179/LDHA axis, providing a new insight into the clinical application of Matrine in HCC treatment.